Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 2

Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer

Sayfa
650–656
Yayın Tarihi
2022-11-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: In this study, cut-off value was calculated as 46.5 pg/mL for basal CT, whereas 285 pg/mL for PS peak CT in the diagnosis of preoperative MTC.Key words: Medullary thyroid cancer, C cell hyperplasia, calcitonin, pentagastrin, cut-of

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Medullary thyroid cancer (MTC) originates from parafollicular cells (C cell) and produces calcitonin (CT).
📊
Temel Bulgular & Veri:If basal CT level is 100 pg/mL or higher, it is likely to have MTC, but if basal CT level is below 10 pg/mL, the probability of developing thyroid disease is low.
💡
Sonuç & Katkı:Conclusion: In this study, cut-off value was calculated as 46.5 pg/mL for basal CT, whereas 285 pg/mL for PS peak CT in the diagnosis of preoperative MTC.Key words: Medullary thyroid cancer, C cell hyperplasia, calcitonin, pentagastrin, cut-of
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Medullary thyroid cancer (MTC) originates from parafollicular cells (C cell) and produces calcitonin (CT). Basal serum CT was used in the diagnosis and treatment of MTC. If basal CT level is 100 pg/mL or higher, it is likely to have MTC, but if basal CT level is below 10 pg/mL, the probability of developing thyroid disease is low. In cases with basal CT level between 10–100 pg/mL, pentagastrin-stimulated (PS) CT level is studied to evaluate MTC and C cell hyperplasia (CHH). This study aimed to determine cut-off value for basal and PS peak CT level for diagnosis of MTC. Materials and methods: We retrospectively reviewed files of patients presented to endocrine outpatient clinic of Ege University, Medicine School, between 2010 and 2019; 176 patients with basal CT level of 10–100 pg/mL and patients with PS test were included to the study. Results: The receiver operating characteristic curve (ROC) analysis was used to determine cut-off value for basal CT that can discriminate cases with MTC and those with nodular goiter. Cut-off value for basal CT was calculated as 46.5 pg/mL (specificity; 100 %, sensitivity; 74 %). In the ROC analysis for peak PS CT, cut-off value was calculated as 285 pg/mL (specificity:100 %; sensitivity:82 %). When peak CT level was > 290 pg/mL in PS test, both specificity and sensitivity for MTC were determined as 100 %. The PS peak CT level > 285 pg/ mL was significant for MTC diagnosis while range of 117–274 pg/mL was significant for CHH. Conclusion: In this study, cut-off value was calculated as 46.5 pg/mL for basal CT, whereas 285 pg/mL for PS peak CT in the diagnosis of preoperative MTC.Key words: Medullary thyroid cancer, C cell hyperplasia, calcitonin, pentagastrin, cut-of

🔖

Bu Makaleye Atıf Yap

BAYKAN, E. K., ERDOĞAN, M. (2022). Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 650–656. https://ajindex.com/articles/609358

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Cohen R, Campos J-M, Salaün C, Massoud Heshmati H, Kraimps J-L et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. The Journal of Clinical Endocrinology & Metabolism 2000
  2. 85 (2): 919-919. doi:10.1210/jcem.85.2.6556 2. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proceedings of the National Academy of Sciences of the United States of America 1994
  3. 91 (4): 1579- 1583. doi:10.1073/pnas.91.4.1579 3. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 1993
  4. 2 (7): 851-856. doi:10.1093/hmg/2.7.851 4. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: Results in 899 patients. Clinical Endocrinology 1998
  5. 48 (3): 265-273. doi:10.1046/ j.1365-2265.1998.00392.x 5. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Journal of Clinical Endocrinology and Metabolism. 2007
  6. 92 (2): 450-455. doi:10.1210/jc.2006-1590 6. Pina G, Dubois S, Murat A, Berger N, Niccoli P et al. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? Clinical Endocrinology. 2013
  7. 78 (3): 358-364. doi:10.1111/cen.12001 7. Toledo SPA, Lourenço DM, Santos MA, Tavares MR, Toledo RA et al. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics. 2009
  8. 64 (7): 699-706. doi:10.1590/S1807-59322009000700015 8. Guyétant S, Rousselet M-C, Durigon M, Chappard D, Franc B et al. Sex-Related C Cell Hyperplasia in the Normal Human Thyroid: A Quantitative Autopsy Study. The Journal of Clinical Endocrinology & Metabolism. 1997
  9. 82 (1): 42-47. doi:10.1210/ jcem.82.1.3684 9. Hazard JB, Hawk WA, Crile G. Medullary (solıd) carcınoma of the thyroıd—a clınıcopathologıc entıty. Journal of Clinical Endocrinology and Metabolism 1959
  10. 19 (1): 152-161. doi:10.1210/jcem-19-1-152 10. Melvin KE, Tashjian AH. The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid. Proceedings of the National A